<DOC>
	<DOC>NCT00260923</DOC>
	<brief_summary>This is a study for people diagnosed with hypertension to compare 3 doses (75 mg, 150 mg, and 300 mg) of an experimental product, aliskiren in comparison to a placebo. Each patient is in the study for 8 weeks</brief_summary>
	<brief_title>A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren in Patients With High Blood Pressure</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>Male and female outpatients 18 years of age and older Patients who are eligible and able to participate in the study Severe hypertension History or evidence of a secondary form of hypertension History of hypertensive encephalopathy or cerebrovascular accident. Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>hypertension</keyword>
	<keyword>aliskiren</keyword>
	<keyword>blood pressure</keyword>
</DOC>